>

First Randomized Clinical Trial on "Periodontal Therapy and CHD Risk Markers" from Asia by Dr. SAH Bokhari & Dr. Ayyaz A Khan

It is a matter of honour and pride that a research paper titled "Non-Surgical Periodontal Therapy Reduces Coronary Heart Disease Risk Markers: A Randomized Controlled Trial" by Prof. Dr. SAH Bokhari, Prof. Dr. AA Khan and colleagues has been published in the Journal of Clinical Periodontology (JCP2012;39) (Internationally first ranking journal of dentistry). Prof. M. Tonetti, Editor-in-Chief of J Clin Periodontol has declared this research work as a truly interesting piece of research. Therefore this research has also been selected for presentation on 'PubCast' that is video link website (www.scivee.tv/) where the author/s of high quality research work are given chance to have a talk about their research. Dr. Bokhari's PubCast is available on this website (www.scivee.tv/node/53516 ) and has been viewed by 418 individuals within one months of upload. This clinical trial was funded by HEC and was conducted at Punjab institute of cardiology with the academic cooperation of Punjab University and Sheikh Zayed PGMI Lahore. This is the first randomized trial from Asia in the field of Perio-CHD connections. The principal finding of this research is that treatment of periodontal disease reduces CHD risk by 12.5% in CHD patients who were at high risk despite having cardiac medications. ng a prescription so parents can measure and administer the correct dose to their children," said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research. "Parents and pediatricians must make sure children receive only the amount of Tamiflu appropriate for their weight. In October, the FDA ordered operators of about 4,100 websites to immediately stop selling unapproved medications to U.S. consumers. The vast majority of those sites were operated by Canada Drugs. The site was still operating Friday. Genuine Botox is made by Allergan Inc., based in Irvine, Calif. Avastin is made by Roche Holding AG's Genentech unit. rst between the sabre-toothed and conical-toothed cats, and then between small-medium and large cats." e, and we'll work even harder in the two areas where we've identified some concerns," Janek said. "We're going to make sure that every woman who qualifies for these services is able to get them."